HappeningToo topic
Levothyroxine Sodium Anhydrous reports
Browse community reports connected to Levothyroxine Sodium Anhydrous. These reports can show that other people are describing similar experiences, but they do not prove that Levothyroxine Sodium Anhydrous caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
45 problems
Abdominal Discomfort while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and abdominal discomfort appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and abdominal pain upper appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and abdominal pain appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and acid reflux appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and alopecia appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and anxiety appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and back pain appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and constipation appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and cough appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and decreased appetite appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and dehydration appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and diarrhea appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and dizziness appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and dry mouth appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and dry skin appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and excessive sweating appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and fatigue appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and feeling abnormal appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and flushing appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and headache appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and heart rate increased appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and hives appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and hypotension appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and insomnia appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and itching appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and malaise appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and migraine appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and muscle spasms appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and muscular weakness appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and myalgia appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and nausea appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and pain appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and palpitations appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and peripheral swelling appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and rash appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and shortness of breath appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and skin redness appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and sleepiness appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tachycardia while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and tachycardia appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and tingling or pins and needles appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and tremor appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and vomiting appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and weakness appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and weight decreased appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Levothyroxine Sodium Anhydrous
FDA FAERS contains adverse-event reports in which Levothyroxine Sodium Anhydrous and weight increased appear together. This does not establish that Levothyroxine Sodium Anhydrous caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →